Literature DB >> 9374175

Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss.

D R Trune1.   

Abstract

Immunoglobulin staining was conducted in cochlear tissue from the C3H/lpr autoimmune strain mouse to better understand the local immune processes underlying autoimmune inner ear disease. This mouse is a model for spontaneous systemic lupus erythematosus with coincident elevated cochlear thresholds. Cochleas were examined from C3H/lpr mice at 2 months of age, before disease onset, and at 8 months of age, when systemic disease and hearing loss are manifested. Sections of these cochleas, along with cochlear sections from age-matched C3H/HeJ nonautoimmune controls, were immunocytochemically stained for IgG and IgM to identify areas of abnormal immunoglobulin activity. IgM immunoreactivity was similar in control and autoimmune cochlear tissue and did not appear to vary with disease progression. Staining was limited to the inside of capillaries in the stria vascularis and other areas within the cochlea. Similar staining patterns were seen in control animals stained for IgG. However, C3H/lpr mice with autoimmune disease showed extensive IgG immunoreactivity spreading out from the stria vascularis capillaries into the extracapillary spaces. This increased permeability suggested that breakdown of the blood labyrinth barrier was coincident with systemic autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374175     DOI: 10.1016/s0194-5998(97)70022-6

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

1.  Culture media-based selection of endothelial cells, pericytes, and perivascular-resident macrophage-like melanocytes from the young mouse vestibular system.

Authors:  Jinhui Zhang; Songlin Chen; Jing Cai; Zhiqiang Hou; Xiaohan Wang; Allan Kachelmeier; Xiaorui Shi
Journal:  Hear Res       Date:  2017-01-11       Impact factor: 3.208

2.  Survival of partially differentiated mouse embryonic stem cells in the scala media of the guinea pig cochlea.

Authors:  Michael S Hildebrand; Hans-Henrik M Dahl; Jennifer Hardman; Bryony Coleman; Robert K Shepherd; Michelle G de Silva
Journal:  J Assoc Res Otolaryngol       Date:  2005-12

3.  Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Authors:  Keiko Hirose; Jared J Hartsock; Shane Johnson; Peter Santi; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2014-06-21

4.  Vascular Pathophysiology in Hearing Disorders.

Authors:  Dennis R Trune; Anh Nguyen-Huynh
Journal:  Semin Hear       Date:  2012-08

5.  Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement.

Authors:  M Tucci; C Quatraro; F Silvestris
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 6.  Autoimmune inner ear disease.

Authors:  J T Roland
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

7.  Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides.

Authors:  C Arturo Solares; Andrea E Edling; Justin M Johnson; Moo-Jin Baek; Keiko Hirose; Gordon B Hughes; Vincent K Tuohy
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 8.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

9.  Fetal Hox11 expression patterns predict defective target organs: a novel link between developmental biology and autoimmunity.

Authors:  Anna Lonyai; Shohta Kodama; Douglas Burger; Denise L Faustman
Journal:  Immunol Cell Biol       Date:  2008-02-26       Impact factor: 5.126

10.  Strial microvascular pathology and age-associated endocochlear potential decline in NOD congenic mice.

Authors:  Kevin K Ohlemiller; Mary E Rybak Rice; Patricia M Gagnon
Journal:  Hear Res       Date:  2008-08-12       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.